Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Relapsed/Refractory Multiple Myeloma (United States and Western Europe, Japan, Singapore, Canada and Brazil)
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Aplastic Anemia - Patient Education and Support (Europe)
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine All
Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal disease
Release Date:
Review Process: Pfizer Internal
Research Vaccines Algeria, Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Oman, Qatar, Saudi Arabia, Tunisia, United Arab Emirates
Enhance Clinical Research Capacity and Capability in China
Release Date:
Review Process: Pfizer Internal
Education Support for the Professions China
Optimizing Telemedicine/Telehealth for the Rheumatology Community
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Quality of Care Initiative to Improve the Treatment of Locally Advanced or Metastatic (Stage IV) Bladder Cancer Patients
Release Date:
Partner: National Comprehensive Cancer Network, EMD Serono
Review Process: Expert Review Panel
Quality Improvement Oncology USA
Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease by a Multidisciplinary Team
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease All
Improving NOAC adherence and persistence, initiatives for pharmacists
Release Date:
Review Process: Pfizer Internal
Quality Improvement Internal Medicine Israel
Review and Analysis of Retrospective, Local Source, Serotype Distribution for Invasive Pneumococcal Disease in Latin America
Release Date:
Review Process: Pfizer Internal
Research Vaccines All
Invasive Fungal Infections Research in China
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Addressing Knowledge Gaps in Inflammatory Bowel Disease (IBD) Care
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA